Massachusetts

Consumer Healthcare Experience State Survey

A survey of more than 1,150 Massachusetts adults, conducted from May 7, 2021 to May 25, 2021, found that:

More than half (51%) experienced healthcare affordability burdens in the past year;
Almost 3 in 4 (74%) are worried about affording healthcare in the future;
Over half (51%) are worried about affording treatment for COVID-19 if they need it; and
Across party lines, respondents express strong support for government-led solutions.

Altarum’s Consumer Healthcare Experience State Survey (CHESS) is designed to elicit respondents’ unbiased views on a wide range of health system issues, including confidence using the health system, financial burden and views on fixes that might be needed.

Below are Data Briefs with statewide and regional survey results.

2021 Survey Reports

Affordability

Prescription Drugs

Recent Surveys

Massachusetts Residents Struggle to Afford High Healthcare Costs; Worry About Affording Care, Leading to Support for Government Actions to Address High Healthcare Costs

Key Findings A survey of more than 1,150 Massachusetts adults, conducted from May 7, 2021 to May 25, 2021, found that: Survey context: During the survey period, Massachusetts residents were in phase four of the state’s reopening plan and the state was at…

Massachusetts Residents Worried about High Drug Costs; Support a Range of Government Solutions

According to a survey of over 1,150 Massachusetts adults conducted from May 7, 2021 to May 25, 2021, residents are concerned about prescription drug costs and express a strong desire for policy solutions. Almost half of all survey respondents (47%) reported being either “somewhat worried”…

Altarum in Action

Rhode Island Office of the Health Insurance Commissioner cites CHESS survey in letter to State House Committee on Health and Human Services about HB072 related to reimbursement rates and repealing affordability standards. Read more

Washington State Senator Patty Murray’s office cites the WA CHESS survey in press release about Senate Health, Education, Labor and Pensions (HELP) Committee hearing where Senator Murray questioned CEOs of major pharmaceutical companies about the high prices charged to Americans for their prescription drugs. Read more